From Seekingalpha · Gary Gambino · · 40s
Thermo Fisher Q3 Growth Beats
Thermo Fisher's Q3 results show 6% organic growth and raised full-year guidance.
In brief
Thermo Fisher's Q3 results show 6% organic growth and raised full-year guidance. Thermo Fisher Scientific reported 6% organic growth, EPS and sales beats, and raised full-year guidance after strong clinical research and bioproduction demand. Originally reported by Seekingalpha.
Q3 Results Confirm Return To Growth
Thermo Fisher Scientific delivered strong Q3 results with 6% organic growth, EPS and sales beats, and raised full-year guidance.
Growth Drivers
Robust demand in clinical research, bioproduction, and electron microscopy supported by recent strategic acquisitions.
Financial Health
Operating margin reached 24.5%, aided by divestitures, acquisitions, and process improvements.
Here's the gist
Thermo Fisher Scientific reported 6% organic growth, EPS and sales beats, and raised full-year guidance after strong clinical research and bioproduction demand.
